Labshake search

101 - 150 of 1835 citations for Diethyl 2 chlorothiazol 5 yl methylphosphonate since 2020

• Characterization of Collaborative Cross mouse founder strain CAST/EiJ as a novel model for lethal COVID-19

  Candice N. Baker, et al., bioRxiv - Immunology 2024

  Quote: ... CD64 (X54-5/7.1) (Biolegend); CD335 (29A1.4) ...
• Lung Microbiome Intervention Attenuates Herpesvirus-Induced Post-HCT Pulmonary Fibrosis Through PD-L1 Upregulation on Dendritic Cells

  Joshua B. Perkins, et al., bioRxiv - Immunology 2024

  Quote: ... CD64 (X54-5/7.1, BioLegend), CD24 (M1/69 ...
• Polyphosphate mobilization influences the ability of Cryptococcus neoformans to cause disease in a murine model of cryptococcosis

  Kabir Bhalla, et al., bioRxiv - Microbiology 2024

  Quote: ... CD4 (RM4-5) from BioLegend; NK1.1 (PK136) ...
• Kupffer cell and recruited macrophage heterogeneity orchestrate granuloma maturation and hepatic immunity in visceral leishmaniasis

  Gabriela Pessenda, et al., bioRxiv - Immunology 2024

  Quote: ... CD64 (X54-5/7.1, Biolegend) 1:200 ...
• 4-week GLP immunotoxicity assessment of lactoferrin alpha produced by Komagataella phaffii in Sprague Dawley rats

  Ross Peterson, et al., bioRxiv - Pharmacology and Toxicology 2024

  Quote: ... CD11b (clone WT.5) (Biolegend), CD25 (clone OX-39 ...
• Single cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine

  Suhas Sureshchandra, et al., bioRxiv - Immunology 2021

  Quote: ... IgD (IA6-2, BioLegend), CD27 (M-T271 ...
• Lateral plate mesoderm cell-based organoid system for NK cell regeneration from human pluripotent stem cells

  Dehao Huang, et al., bioRxiv - Immunology 2021

  Quote: ... TRAIL (Biolegend, RIK-2), FasL (Biolegend ...
• The NK receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells

  Sumit Sen Santara, et al., bioRxiv - Immunology 2021

  Quote: ... 2 μM monensin (BioLegend) and 3 μM brefeldin A (BD ...
• The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation

  Danielle Minns, et al., bioRxiv - Immunology 2020

  Quote: ... IL-2 (Biolegend, #431004) and IL-22 (Biolegend ...
• Systemic and mucosal mobilization of granulocyte subsets during lentivirus infection

  Rhianna Jones, et al., bioRxiv - Immunology 2021

  Quote: ... CD32 (FUN-2; BioLegend), CD95 (DX2 ...
• Regeneration of humoral immunity from pluripotent stem cells by defined transcription factors

  Qi Zhang, et al., bioRxiv - Immunology 2021

  Quote: ... CD138(281-2, BioLegend), CD38(90 ...
• Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection

  Suhas Sureshchandra, et al., bioRxiv - Immunology 2021

  Quote: ... IgD (IA6-2, BioLegend), CD27 (M-T271 ...
• Circulating mast cell progenitors migrate to atopic dermatitis-like skin then adapt locally

  Yuki Honda Keith, et al., bioRxiv - Immunology 2022

  Quote: ... integrinβ2 (M18/2; BioLegend), IgE (R35-72 ...
• Integration of Avidity and Differentiation is enabled by CD8⁺ T-cell sensing of IFN-γ

  Lion F.K. Uhl, et al., bioRxiv - Immunology 2023

  Quote: ... IL-2 (Biolegend, #575404), IL-1β (Biolegend ...
• Type I interferon dynamics determines memory B cell epigenetic identity in chronic viral infection

  Lucy Cooper, et al., bioRxiv - Immunology 2023

  Quote: ... or 2 (Biolegend #155863) for 20 minutes at 4°C ...
• Novel Fas-TNFR chimeras that prevents Fas ligand-mediated kill and signals synergistically to enhance CAR T-cell efficacy

  Callum McKenzie, et al., bioRxiv - Synthetic Biology 2023

  Quote: ... IL-2 (Biolegend; 431804), CCL1 (R&D Systems ...
• Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-T_SCM cells using qCART, the Quantum pBac-based CAR-T system

  Peter S. Chang, et al., bioRxiv - Cancer Biology 2022

  Quote: ... and IL-2 (BioLegend) were quantified by ELISA according to manufacturer’s instructions.
• Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells

  Yuhao Shi, et al., bioRxiv - Cancer Biology 2023

  Quote: ... CD8b.2 (Biolegend, 140416), Granzyme B (Biolegend ...
• Lung Microbiome Intervention Attenuates Herpesvirus-Induced Post-HCT Pulmonary Fibrosis Through PD-L1 Upregulation on Dendritic Cells

  Joshua B. Perkins, et al., bioRxiv - Immunology 2024

  Quote: ... CD8a (Ly-2, BioLegend), and CCR6 (29-2L17 ...
• Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation

  Hrishikesh S. Kulkarni, et al., bioRxiv - Immunology 2024

  Quote: ... CD138 (281-2; Biolegend) CD38 (S21016F ...
• Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

  Yunlong Cao, et al., bioRxiv - Immunology 2022

  Quote: ... 2 μl PE/Cyanine7 anti-human IgD antibody (BioLegend, 348210, clone: IA6-2), 0.13 μg biotinylated SARS-CoV-2 BA.2 RBD protein (customized from Sino Biological ...
• Long-term efficacy of adoptive cell therapy is determined by host CD8⁺ T cells and undermined by lymphodepleting preconditioning

  Diego Figueroa, et al., bioRxiv - Immunology 2024

  Quote: ... 100 UI/mL of recombinant human IL-2 (rhIL-2; Biolegend, ref 589108) and 50 μM of 2-mercaptoethanol (Merck ...
• Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain

  Xiao Niu, et al., bioRxiv - Immunology 2024

  Quote: ... 2 μL PE/Cyanine7 anti-human IgD antibody (BioLegend, 348210, clone: IA6-2), 0.013 μg biotinylated SARS-CoV-2 BA.5/BF.7 NTD protein (Sino Biological ...
• Reconstitution of Alveolar Regeneration via novel DATPs by Inflammatory Niches

  Jinwook Choi, et al., bioRxiv - Cell Biology 2020

  Quote: ... CD64 (X54-5/7.1)-PeCy7 (Biolegend), CD24(M1/69)-APC (eBioscience) ...
• CXCR2 inhibition enables NASH-HCC immunotherapy

  Jack Leslie, et al., bioRxiv - Cancer Biology 2022

  Quote: ... CD45 (Biolegend, 5 µg, 30-F11), CD101 (eBioscience ...
• Human SLC46A2 is the dominant cGAMP importer in extracellular cGAMP-sensing macrophages and monocytes

  Anthony F. Cordova, et al., bioRxiv - Cancer Biology 2021

  Quote: ... 5 μg/mL Brefeldin A (BioLegend) was added to each sample ...
• CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infection

  Abigail Vanderheiden, et al., bioRxiv - Immunology 2021

  Quote: ... CD64: PerCpCy5.5 (Biolegend, X54-5/7.1), F4/80:FITC (Biolegend ...
• Supraphysiological testosterone induces ferroptosis and activates NF-kappaB mediated immune pathways in prostate cancer through nucleophagy

  Janet Mendonca, et al., bioRxiv - Cancer Biology 2020

  Quote: ... stained with 5 μM CFSE (Biolegend) for 10 min at 37 °C ...
• Genome-wide Screens Identify Lineage- and Tumor Specific-Genes Modulating MHC-I and MHC-II Immunosurveillance in Human Lymphomas

  Devin Dersh, et al., bioRxiv - Cancer Biology 2020

  Quote: ... 5 μg/mL brefeldin A (Biolegend) was added to one column of wells 18 hours prior to collection to serve as negative controls ...
• Dynamically Linking Influenza Virus Infection Kinetics, Lung Injury, Inflammation, and Disease Severity

  Margaret A. Myers, et al., bioRxiv - Systems Biology 2021

  Quote: ... CD4 (FITC, clone RM4-5, Biolegend), CD8α (BV605 ...
• Regulatory T cell expansion by a highly CD25-dependent IL-2 mutein arrests ongoing autoimmunity

  Liliane Khoryati, et al., bioRxiv - Immunology 2020

  Quote: ... anti-CD4 BV785 (RM4-5, BioLegend), anti-CD8α V500 and anti-CD8α BUV395 (53-6.7 ...
• Genetic models of latent tuberculosis in mice reveal differential control by adaptive immunity

  Hongwei Su, et al., bioRxiv - Microbiology 2021

  Quote: ... BV605 anti-CD4 (RM4-5, BioLegend), BV711 anti-CD8 (53-6.7 ...
• Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia

  Michele Petruzzelli, et al., bioRxiv - Cancer Biology 2021

  Quote: ... CD64 (X54-5/7.1 BioLegend, BV711), CD127 (SB/199 ...
• CXCR2 inhibition enables NASH-HCC immunotherapy

  Jack Leslie, et al., bioRxiv - Cancer Biology 2022

  Quote: ... CD3 (Biolegend, 5 µg, 145-2C11), CD8 (Biolegend ...
• CXCR2 inhibition enables NASH-HCC immunotherapy

  Jack Leslie, et al., bioRxiv - Cancer Biology 2022

  Quote: ... CD8 (Biolegend, 5 µg, 53-6.7), CD31 (Biolegend ...
• Arresting microbiome development limits immune system maturation and resistance to infection

  Jean-Bernard Lubin, et al., bioRxiv - Immunology 2022

  Quote: ... FITC-CD4 (clone Rm4-5; Biolegend), APC-Foxp3 (FJK-16s ...
• Lipocalin 2 dictates cancer cell plasticity elicited by therapy-induced senescence

  Jorge Morales-Valencia, et al., bioRxiv - Cancer Biology 2022

  Quote: ... 5 uL of Annexin V (BioLegend) was added to cells resuspended in 200 uL of binding buffer (BioLegend) ...
• The chromatin associated Sin3B is a critical regulator of DNA damage repair through the engagement of the Non-Homologous End Joining

  Jorge Morales-Valencia, et al., bioRxiv - Cancer Biology 2022

  Quote: ... 5 uL of Annexin V (BioLegend) was added to cells resuspended in 200 uL of binding buffer (BioLegend) ...
• Structurally and functionally distinct early antibody responses predict COVID-19 disease trajectory and mRNA vaccine response

  Saborni Chakraborty, et al., bioRxiv - Immunology 2021

  Quote: ... anti-CD2 (BioLegend; clone RM2-5), anti-CD3 (BioLegend ...
• Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing

  Nina Frey, et al., bioRxiv - Cancer Biology 2021

  Quote: ... CD64 BV421 (X54-5/7.1; BioLegend), TNF FITC (MP6-XT22 ...
• Developmentally regulated PERK activity renders dendritic cells insensitive to subtilase cytotoxin-induced integrated stress response

  Andreia Mendes, et al., bioRxiv - Immunology 2020

  Quote: ... CD64 (X54-5/7.1) from BioLegend; Sirpα (P84) ...
• FMRP DIRECTLY INTERACTS WITH R-LOOP AND SHOWS COMPLEX INTERPLAY WITH THE DHX9 HELICASE

  Arijita Chakraborty, et al., bioRxiv - Biochemistry 2022

  Quote: ... 5 μg mouse IgG control (Biolegend) or 4 μg rabbit IgG (Bethyl laboratories ...
• Interdependence of CTL and NK cell cytotoxicity against melanoma cells

  Kim S. Friedmann, et al., bioRxiv - Immunology 2020

  Quote: ... and 5 μl 7-AAD (Biolegend) were added ...
• Discovery of A New Class of Integrin Antibodies for Fibrosis

  Ji Zhang, et al., bioRxiv - Pharmacology and Toxicology 2020

  Quote: ... 5 ng/ml TGFβ (Biolegend #580702) ± inhibitors ...
• ILC homeostasis phenotyping in various tissues, aging, and sex differences

  Alexis S Mobley, et al., bioRxiv - Immunology 2021

  Quote: ... Brilliant Violet 421-IL-5 (Biolegend), and APC-IL-4 (Tonbo Bioscience ...
• Conditional deletion of HIF-1α provides new insight regarding the murine response to gastrointestinal infection with Salmonella Typhimurium

  Laura Robrahn, et al., bioRxiv - Microbiology 2021

  Quote: ... and CD64 (Biolegend, X54-5/7.1).
• P2X7 receptor signaling is not required but can enhance Th17 differentiation

  Yin Yang, et al., bioRxiv - Immunology 2021

  Quote: ... 5 ng/ml TGF-β1 (Biolegend), 20 ng/ml IL-23 (Miltenyi) ...
• IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to Toxoplasma gondii

  Joseph T. Clark, et al., bioRxiv - Immunology 2021

  Quote: ... CD64 FcgRI (X54-5/7.1, Biolegend), MHC II I-A/I-E (m5/114.15.2 ...
• Bone Marrow-Derived Cells Contribute to the Maintenance of Thymic Stroma including Thymic Epithelial Cells

  Shami Chakrabarti, et al., bioRxiv - Immunology 2020

  Quote: ... CD4-biotinylated(clone RM4-5, BioLegend), CD8 – biotinylated (clone53-6.7 ...
• Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell epitope mapping

  Felix Schreibing, et al., bioRxiv - Immunology 2021

  Quote: ... 5 μl Human TruStain FcX (BioLegend) was added and incubated for 10 minutes at 4°C ...